Heidelberg Pharma AG
XETRA:HPHA
During the last 3 months Heidelberg Pharma AG insiders have not bought any shares, and have not sold any shares. The stock price has increased by 21% over this period (open performance analysis).
The last transaction was made on
Aug 28, 2024
by
Miller, Walter
(Chief Financial Officer)
, who
bought
5k EUR
worth of HPHA shares.
During the last 3 months Heidelberg Pharma AG insiders have not bought any shares, and have not sold any shares. The stock price has increased by 21% over this period (open performance analysis).
The last transaction was made on
Aug 28, 2024
by
Miller, Walter
(Chief Financial Officer)
, who
bought
5k EUR
worth of HPHA shares.
Heidelberg Pharma AG
Glance View
Heidelberg Pharma AG is a biopharmaceutical company, which engages in the research and development of drugs for cancer patients. The company is headquartered in Ladenburg, Baden-Wuerttemberg and currently employs 89 full-time employees. The company went IPO on 2006-11-13. The firm focuses on the research and development of therapy treatments for oncology area. The company aims at applying toxin Amanitin into cancer therapies using its Antibody Targeted Amanitin Conjugate (ATAC) technology. The Company’s pipeline includes a number of drug candidates, such as HDP-101, a B-cell maturation antigen ATAC for multiple myeloma; PSMA-ATAC, prostate-specific membrane antigens, and CD19-ATAC, a B-lymphocyte antigen. Through partnerships, the Company develops clinical assets, including MESUPRON, REDECTANE and RENCAREX. The company also offers preclinical contract research services.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet